NCT06951737

Completed

Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibr...

Bursa Postgraduate Hospital Source

Compare

Other study identifiers

Sponsor study identifier

Bursa SUAM

Study Type

observational

Actual enrollment (reported)

120

Locations

1 country

Sites

1

Timeline

Study Start

October 2, 2022

Actual (reported)

Primary Completion

April 2, 2024

Actual (reported)

Study Completion

October 2, 2024

Actual (reported)

Brief Summary

Consecutive DCCV was performed until to achieve 120 patients in SR (60 DM patients who used SGLT-2 inhibitors and 60 DM patients who did not use SGLT-2 inhibitors). Patients defined as SGLT-2 inhibitor user group and control group. The two groups were monitored for AF recurrence on the first day, then at one, three, and six months after CV.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 120 participants
Study completion date: October 2, 2024
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 2, 2022
Actual (reported)
Primary Completion
April 2, 2024
Actual (reported)
Study Completion
October 2, 2024
Actual (reported)
First Submitted
April 20, 2025
Actual (reported)
First Posted
April 30, 2025
Actual (reported)

Last Updated: June 3, 2025
Status Verified: June 2025
Last Update Submitted: June 1, 2025

Conditions

Atrial Fibrillation (AF)Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

Atrial fibrillation recurrence
six month

Study Arms (1)

SGLT-2 inhibitor user

patients with diabetes mellitus, atrial fibrillation and using SGLT-2 inhibitor

Eligibility Criteria

Age18 Years - 90 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients diagnosed with DM and AF who were planned to undergo electrical cardioversion were evaluated for suitability for the study.

You may qualify if:

patients \> 18 years and \< 90 years,

Sponsors & Collaborators

Bursa Postgraduate Hospital
Otherlead

Study Sites (1)

Bursa Yüksek İhtisas Hastanesi

Bursa, Turkey (Türkiye)

Related Publications (1)

Yarar M, Ari H, Ari S, Tutuncu A, Melek M, Bozat T. Evaluation of the effect of SGLT-2 inhibitors on atrial fibrillation recurrence in diabetic patients. Expert Opin Pharmacother. 2025 Aug;26(11-12):1343-1349. doi: 10.1080/14656566.2025.2527189. Epub 2025 Jul 3.
PMID: 40579747DERIVED

MeSH Terms

Conditions

Diabetes MellitusAtrial Fibrillation

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Enrollment

120 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Prof Dr

Study Record Dates

First Submitted

April 20, 2025

First Posted

April 30, 2025

Study Start

October 2, 2022

Actual (reported)

NCT05566912

Practices Made by Patients to Avoid Insulin Injection Pain

Completed

NCT05976191

Comparison of Fasting Blood Glucose Measurements From Fingertip and Intravenous on Patient Satisfaction in Patients With Diabetes Mellitus

Not ApplicableUnknown

NCT06591962

The Comparison of Biopsychosocial Characteristics with and Without Diabetes Mellitus

Unknown

NCT05893784

The Effect of Progressive Relaxation Exercises Applied to Individuals With Diabetes on Fatigue and Sleep

Not ApplicableCompleted

NCT06644235

Pain and Comfort in Diabetic Foot Ulcer Care

Not ApplicableCompleted

NCT04754360

Cut-off Values of 6-min Walk Test and Sit-to-stand Test for Determining Symptom Burden and Functional Impairment in Atrial Fibrillation

Completed

Patient diagnosed with DM

Patient underwent electrical cardioversion due to AF and was restored to sinus rhythm

You may not qualify if:

patient who are not suitable for anticoagulant use,
have thyroid dysfunction,
glomerular filtration rate ≤ 25 ml/min/1.73 m²,
patients whose sinus rhythm cannot be achieved with electrical cardioversion,
malignancy patients,
patients with acute or chronic inflammatory disease,
patients with peripheral artery disease,
patients with pacemakers,
patients with advanced valve stenosis or insufficiency,
patients who have had coronary bypass surgery,
patients with percutaneous or surgical bioprosthesis or metallic valve surgery.

Contact the study team to confirm eligibility.

Primary Completion

April 2, 2024

Actual (reported)

Study Completion

October 2, 2024

Actual (reported)

Last Updated

June 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT06951737
Data provider: ClinicalTrials.gov
Source updated: 2025-06-03
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:41 UTC

Locations

TR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

SGLT-2 inhibitor user

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations